Solid Biosciences (SLDB) Tops Q2 EPS by 7c
Solid Biosciences (NASDAQ: SLDB) reported Q2 EPS of ($0.38), $0.07 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.
Solid Biosciences (NASDAQ: SLDB) reported Q2 EPS of ($0.38), $0.07 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.